STLN
Starling Oncology Inc.
STLN | NASDAQ
$6.53
-$0.12 (-1.80%)
At close: Oct 30, 2026, 3:59 PM ET
$6.62
+$0.09 (+1.38%)
Pre-market:
Nov 2, 2026, 7:09 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Cash & Equivalents | 33.57M |
Short-Term Investments | n/a |
Long-Term Investments | n/a |
Other Long-Term Assets | 606K |
Receivables | 59.32M |
Inventory | 16.88M |
Other Current Assets | 2.99M |
Total Current Assets | 112.75M |
Property-Plant & Equipment | 33.06M |
Goodwill & Intangibles | 18.25M |
Total Long-Term Assets | 51.91M |
Total Assets | 164.66M |
Account Payables | 43.17M |
Deferred Revenue | 2.28M |
Short-Term Debt | n/a |
Other Current Liabilities | 13.15M |
Total Current Liabilities | 70.96M |
Long-Term Debt | 77.4M |
Other Long-Term Liabilities | 12.88M |
Total Long-Term Liabilities | 109.41M |
Total Liabilities | 180.38M |
Total Debt | 103.69M |
Book Value | -15.72M |
Book Value Per Share | -0.17 |
Common Stock | 10K |
Retained Earnings | -271.42M |
Comprehensive Income | n/a |
Shareholders Equity | -15.72M |
Total Investments | n/a |
Add to Watchlist
Select watchlists to add or remove STLN